(Q43550717)

English

Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

0 references

1 reference

based on heuristic

inferred from title

Jeffrey J. Olson

1

object named as

Jeffrey J Olson

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Ellen McKenzie

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Megan Skurski-Martin

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Zhaobin Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Daniel Brat

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Surasak Phuphanich

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

5 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

293-299

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

https://scigraph.springernature.com/pub.10.1007/s11060-008-9660-z

0 references

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9660-Z

21 January 2018

Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9660-Z

21 January 2018

Tumorigenesis in transgenic mice in which the SV40 T antigen is driven by the brain-specific FGF1 promoter.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of the response of recurrent malignant gliomas treated with interferon alpha with tumor interferon alpha gene content.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glioblastoma multiforme-report of 267 cases treated at a single institution.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formation of the cross-link 1-[N3-deoxycytidyl),2-[N1-deoxyguanosinyl]ethane in DNA treated with N,N'-bis(2-chloroethyl)-N-nitrosourea.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intron A (interferon alfa-2b): clinical overview and future directions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy for advanced renal cell cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferons as antiangiogenic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic options for recurrent high-grade glioma in adult patients: recent advances

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct demonstration in synthetic oligonucleotides that N,N'-bis(2-chloroethyl)-nitrosourea cross links N1 of deoxyguanosine to N3 of deoxycytidine on opposite strands of duplex DNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18679580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-008-9660-Z

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Dimensions Publication ID

0 references

release_u2p6elodkbdzflijixnyls6ome

1 reference

https://api.fatcat.wiki/v0/release/u2p6elodkbdzflijixnyls6ome

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43550717&oldid=2098255366"